1. Thorough QTc Evaluation and the Safety of Supratherapeutic Doses of Odanacatib in Healthy Subjects. Issue 7 (7th June 2019) Authors: McCrea, Jacqueline; Mostoller, Kate; Mahon, Chantal; Liu, Chengcheng; Liu, Fang; Zajic, Stefan; Panebianco, Deborah; Chakravarthy, Manu; Brandquist, Christine; Gutierrez, Maria; Stoch, S. Aubrey Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 7(2019) Page Start: 861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prednisone has no effect on the pharmacokinetics of CYP3A4 metabolized drugs – midazolam and odanacatib. (25th June 2014) Authors: Marcantonio, Eugene E.; Ballard, Jeanine; Gibson, Christopher R.; Kassahun, Kelem; Palamanda, Jairam; Tang, Cuyue; Evers, Raymond; Liu, Chengcheng; Zajic, Stefan; Mahon, Chantal; Mostoller, Kate; Hreniuk, David; Mehta, Anish; Morris, Denise; Wagner, John A.; Stoch, S. Aubrey Journal: Journal of clinical pharmacology Issue: Volume 54:Number 11(2014:Nov.) Page Start: 1280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early‐stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK‐7288 in excessive daytime sleepiness patients. (4th October 2013) Authors: Sun, Hong; MacLeod, Catherine; Mostoller, Kate; Mahon, Chantal; Han, Lingling; Renger, John J.; Ma, Junshui; Brown, Kevin R.; Schulz, Valerie; Kay, Gary G.; Herring, W. Joseph; Lines, Christopher; Rosen, Laura B.; Murphy, M. Gail; Wagner, John A. Journal: Journal of clinical pharmacology Issue: Volume 53:Number 12(2013:Dec.) Page Start: 1294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗